Nanexa AB Cash Flow Conversion Efficiency

Latest as of June 2026: -0.073x

Nanexa AB cash flow conversion efficiency. Based on the latest financial reports, Nanexa AB (NANEXA) has a cash flow conversion efficiency ratio of -0.073x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-9.66 Million ≈ $-1.04 Million USD) by net assets (Skr132.87 Million ≈ $14.30 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Nanexa AB (2014–2025)

Cash flow conversion efficiency of Nanexa AB from 2014 to 2025. This chart illustrates how Nanexa AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. View NANEXA stock price and chart for real-time trading data and today's change.

Nanexa AB Cash Flow Conversion Ratio Explained

Nanexa AB cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Nanexa AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Nanexa AB ranked by their cash flow conversion efficiency. Also see NANEXA market cap for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
RideNow Group, Inc. NASDAQ:RDNW	0.000x
Alta Equipment Group Inc NYSE:ALTG	-0.735x
Translational Development Acquisition Corp. Ordinary Shares NASDAQ:TDAC	-0.002x
Sol Gel Technologies Ltd NASDAQ:SLGL	0.039x
Bakkt Holdings Inc NYSE:BKKT	-0.071x
Geojit Financial Services Limited NSE:GEOJITFSL	0.018x
Investcorp Europe Acquisition I Corp NASDAQ:IVCB	0.151x
Toubani Resources Ltd AU:TRE	-0.052x

Annual Cash Flow Conversion Efficiency for Nanexa AB (2014–2025)

The table below shows the annual cash flow conversion efficiency of Nanexa AB from 2014 to 2025. Review NANEXA free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr101.53 Million ≈ $10.93 Million	Skr-1.46 Million ≈ $-157.33K	-0.014x	+96.14%
2024-12-31	Skr70.92 Million ≈ $7.63 Million	Skr-26.43 Million ≈ $-2.84 Million	-0.373x	+16.29%
2023-12-31	Skr95.83 Million ≈ $10.31 Million	Skr-42.66 Million ≈ $-4.59 Million	-0.445x	-516.99%
2022-12-31	Skr109.10 Million ≈ $11.74 Million	Skr-7.87 Million ≈ $-847.05K	-0.072x	+56.56%
2021-12-31	Skr151.29 Million ≈ $16.28 Million	Skr-25.13 Million ≈ $-2.70 Million	-0.166x	+57.21%
2020-12-31	Skr43.35 Million ≈ $4.67 Million	Skr-16.83 Million ≈ $-1.81 Million	-0.388x	-2.54%
2019-12-31	Skr24.88 Million ≈ $2.68 Million	Skr-9.42 Million ≈ $-1.01 Million	-0.379x	+8.75%
2018-12-31	Skr16.29 Million ≈ $1.75 Million	Skr-6.76 Million ≈ $-727.11K	-0.415x	-124.54%
2017-12-31	Skr27.46 Million ≈ $2.95 Million	Skr-5.07 Million ≈ $-545.87K	-0.185x	+51.07%
2016-12-31	Skr16.96 Million ≈ $1.83 Million	Skr-6.41 Million ≈ $-689.32K	-0.378x	+30.46%
2015-12-31	Skr6.07 Million ≈ $652.70K	Skr-3.29 Million ≈ $-354.41K	-0.543x	-241.43%
2014-12-31	Skr1.47 Million ≈ $158.09K	Skr563.99K ≈ $60.69K	0.384x	--

About Nanexa AB

ST:NANEXA Sweden Drug Manufacturers - Specialty & Generic

Market Cap

$208.80 Million

Skr1.94 Billion SEK

Market Cap Rank

#16159 Global

#267 in Sweden

Share Price

Skr10.50

Change (1 day)

+1.74%

52-Week Range

Skr1.61 - Skr12.16

All Time High

Skr15.20